Amelioration of experimental arthritis by stroke-induced immunosuppression is independent of Treg cell function

Annals of the Rheumatic Diseases

Volumn 73, Issue 12, 2014, Pages 2183-2191

  Irmler, Ingo M ^a   Gajda, Mieczyslaw ^a   Kamradt, Thomas ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ANIMAL; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CEREBRAL ARTERY DISEASE; DBA MOUSE; EXPERIMENTAL ARTHRITIS; HELPER CELL; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE COUNT; MOUSE; PROTECTION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; BRAIN ISCHEMIA; CELL DIFFERENTIATION; IMMUNE TOLERANCE; IMMUNOCOMPROMISED HOST; INFARCTION, MIDDLE CEREBRAL ARTERY; LYMPHOCYTE COUNT; MICE; MICE, INBRED DBA; MICE, TRANSGENIC; PROTECTIVE FACTORS; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84891010156     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-204148     Document Type: Article

References (49)

1. Steinman L. Elaborate interactions between the immune and nervous systems. Nat Immunol 2004;5:575-81.
2. Czlonkowska A, Cyrta B, Korlak J. Immunological observations on patients with acute cerebral vascular disease. J Neurol Sci 1979;43:455-64.
3. Woiciechowsky C, Asadullah K, Nestler D, et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med 1998;4:808-13.
4. Dirnagl U, Klehmet J, Braun JS, et al. Stroke-induced immunodepression: experimental evidence and clinical relevance. Stroke 2007;38:770-3.
5. Offner H, Vandenbark AA, Hurn PD. Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression. Neuroscience 2009;158:1098-111.
6. Chamorro A, Meisel A, Planas AM, et al. The immunology of acute stroke. Nat Rev Neurol 2012;8:401-10.
7. Haeusler KG, Schmidt WU, Fohring F, et al. Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc Dis 2008;25:50-8.
8. Klehmet J, Harms H, Richter M, et al. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009;158:1184-93.
9. Ren X, Akiyoshi K, Grafe MR, et al. Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity. Metab Brain Dis 2012;27:7-15.
10. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011;365:2205-19.
11. Kamradt T, Mitchison NA. Tolerance and autoimmunity. N Engl J Med 2001;344:655-64.
12. Jacqueline F. A case of evolutive polyarthritis with localisation contralateral to a hemiplegia. Rev Rhum Mal Osteoartic 1953;20:323-4.
13. Thompson M, Bywaters EG. Unilateral rheumatoid arthritis following hemiplegia. Ann Rheum Dis 1962;21:370-7.
14. Kamermann JS. Protective effect of traumatic lesions on rheumatoid arthritis. Ann Rheum Dis 1966;25:361-3.
15. Veale D, Farrell M, Fitzgerald O. Mechanism of joint sparing in a patient with unilateral psoriatic arthritis and a longstanding hemiplegia. Br J Rheumatol 1993;32:413-16.
16. Mulherin D, Bresnihan B, FitzGerald O. Digital denervation associated with absence of nail and distal interphalangeal joint involvement in psoriatic arthritis. J Rheumatol 1995;22:1211-12.
17. Kane D, Lockhart JC, Balint PV, et al. Protective effect of sensory denervation in inflammatory arthritis (evidence of regulatory neuroimmune pathways in the arthritic joint). Ann Rheum Dis 2005;64:325-7.
18. Schubert D, Maier B, Morawietz L, et al. Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J Immunol 2004;172:4503-9.
19. Lahl K, Loddenkemper C, Drouin C, et al. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 2007;204:57-63.
20. Irmler IM, Opfermann T, Gebhardt P, et al. In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography. Arthritis Res Ther 2010;12:R203.
21. Frey O, Bruns L, Morawietz L, et al. B cell depletion reduces the number of autoreactive T helper cells and prevents glucose-6-phosphate isomerase-induced arthritis. PLoS One 2011;6:e24718.
22. Lengl-Janssen B, Strauss AF, Steere AC, et al. The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med 1994;180:2069-78.
23. Berod L, Heinemann C, Heink S, et al. PI3Kgamma deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome. Eur J Immunol 2011;41:833-44.
24. Frey O, Meisel J, Hutloff A, et al. Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis. Ann Rheum Dis 2010;69:1495-501.
25. Frey O, Reichel A, Bonhagen K, et al. Regulatory T cells control the transition from acute into chronic in flammation in glucose-6-phosphate isomerase-induced arthritis. Ann Rheum Dis 2010;69:1511-18.
26. Bockermann R, Schubert D, Kamradt T, et al. Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase. Arthritis Res Ther 2005;7: R1316-24.
27. Tanaka-Watanabe Y, Matsumoto I, Iwanami K, et al. B cells play a crucial role as antigen-presenting cells and collaborate with inflammatory cytokines in glucose-6-phosphate isomerase-induced arthritis. Clin Exp Immunol 2009;155:285-94.
28. Iwanami K, Matsumoto I, Tanaka-Watanabe Y, et al. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum 2008;58:754-63.
29. Frey O, Mitera T, Kelchtermans H, et al. Ameliorated course of glucose-6-phosphate isomerase (G6PI)-induced arthritis in IFN-gamma receptor knockout mice exposes an arthritis-promoting role of IFN-gamma. J Autoimmun 2011;36:161-9.
30. Bruns L, Frey O, Morawietz L, et al. Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice. Arthritis Res Ther 2009;11:R117.
31. Morgan ME, Sutmuller RP, Witteveen HJ, et al. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003;48:1452-60.
32. Huehn J, Siegmund K, Lehmann JC, et al . Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J Exp Med 2004;199:303-13.
33. Nguyen LT, Jacobs J, Mathis D, et al. Where FoxP3-dependent regulatory T cells impinge on the development of inflammatory arthritis. Arthritis Rheum 2007;56:509-20.
34. Kelchtermans H, Geboes L, Mitera T, et al. Activated CD4+CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Ann Rheum Dis 2009;68:744-50.
35. Offner H, Subramanian S, Parker SM, et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 2006;176:6523-31.
36. Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009;15:192-9.
37. Straub RH, Rauch L, Rauh L, et al. Sympathetic inhibition of IL-6, IFN-γ, and KC/CXCL1 and sympathetic stimulation of TGF-β in spleen of early arthritic mice. Brain Behav Immun. 2011;25:1708-15.
38. Vogelgesang A, Grunwald U, Langner S, et al. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 2008;39:237-41.
39. Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med 2003;198:725-36.
40. Gendron A, Teitelbaum J, Cossette C, et al. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats. Brain Res 2002;955:85-97.
41. Schulte-Herbruggen O, Klehmet J, Quarcoo D, et al. Mouse strains differ in their susceptibility to poststroke infections. Neuroimmunomodulation 2006;13:13-18.
42. Offner H, Subramanian S, Parker SM, et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab 2006;26:654-65.
43. Theodorou GL, Marousi S, Ellul J, et al. T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of stroke. Clin Exp Immunol 2008;152:456-63.
44. Vogelgesang A, May VE, Grunwald U, et al. Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS One 2010;5:e8718.
45. Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med 2005;11:1113-17.
46. Frentsch M, Arbach O, Kirchhoff D, et al. Direct access to CD4+ T cells specific for defined antigens according to CD154 expression. Nat Med 2005;11:1118-24.
47. Meier S, Stark R, Frentsch M. The influence of different stimulation conditions on the assessment of antigen-induced CD154 expression on CD4+ T cells. Cytometry A 2008;73:1035-42.
48. Wing JB, Sakaguchi S. Multiple treg suppressive modules and their adaptability. Front Immunol 2012;3:178.
49. Yan J, Read SJ, Henderson RD, et al. Frequency and function of regulatory T cells after ischaemic stroke in humans. J Neuroimmunol 2012;243:89-94.